TRAIL death pathway expression and induction in thyroid follicular cells

Area of Science:

• Cell Biology
• Molecular Oncology
• Immunology

Background:

• Programmed cell death (PCD) is crucial for tissue homeostasis and cancer development.
• The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway is a key mediator of PCD.
• The role of TRAIL in thyroid follicular cell apoptosis remains unclear.

Purpose of the Study:

• To investigate the expression and function of the TRAIL pathway in thyroid follicular cells.
• To determine if TRAIL can induce PCD in thyroid follicular cells and identify factors influencing this process.
• To explore potential sources of TRAIL within the thyroid microenvironment.

Main Methods:

• In vitro studies using primary thyroid follicular cells and a papillary thyroid carcinoma cell line.
• Treatment with purified TRAIL and cycloheximide.
• Assessment of programmed cell death (PCD) induction.
• RNase protection assays to detect TRAIL mRNA expression.
• Cytokine stimulation (interferon gamma, tumor necrosis factor alpha, interleukin 1beta).

Main Results:

• Thyroid follicular cells express TRAIL receptors (death receptor 4 and death receptor 5) but are resistant to TRAIL-induced PCD.
• Co-incubation with cycloheximide sensitizes thyroid cells to TRAIL, enabling rapid and massive PCD.
• Thyroid follicular cells can be induced to express TRAIL mRNA upon stimulation with inflammatory cytokines.
• Intrathyroidal lymphocytes express TRAIL mRNA.
• A papillary thyroid carcinoma cell line mediates TRAIL-dependent killing of a lymphoma cell line.

Conclusions:

• Thyroid follicular cells possess a functional TRAIL pathway, but it is regulated by a labile inhibitor.
• Inflammatory cytokines can overcome this inhibition, inducing TRAIL expression and potentially mediating apoptosis in thyroid cells.
• The TRAIL pathway may play a role in thyroid pathophysiology, including thyroiditis and thyroid cancer.